Aurobindo Pharma Shares Surge 6% as GTCR Nears €4.1 Billion Zentiva Acquisition

Aurobindo Pharma's shares closed 6% higher following reports that GTCR is close to acquiring Zentiva for €4.1 billion. GTCR has outbid other contenders, including Aurobindo Pharma, which had previously expressed interest in Zentiva. The deal is expected to be announced soon. Zentiva, currently owned by Advent International, operates in over 30 countries and employs more than 5,000 people.